Get started
Author

Jascha Ell

Observed names: Ell, Jascha, J., Ell
Institution: Nuremberg Hospital
ORCID: 0000-0002-7176-8581
Observed ORCID: 0000-0002-7176-8581
OpenAlex ID: A5013386565
Downstaging and Pathological Complete Response of Locally Recurrent Sarcomatoid Renal Cell Carcinoma under Pembrolizumab and Lenvatinib: A Case Report and Review of Literature
2023 · Jascha Ell, Philipp Balz, et al. · Case Reports in Oncology · 6
Neural Networks Modeling for Prediction of Required Resources for Personalized Endourologic Treatment of Urolithiasis
2022 · Clemens Huettenbrink, Wolfgang Hitzl, et al. · Journal of Personalized Medicine · 5
PDF
Different ureteral access sheaths sizes for retrograde intrarenal surgery
2023 · Clemens Huettenbrink, Julia Schaldach, et al. · World Journal of Urology · 4
Personalized Prediction of Patient Radiation Exposure for Therapy of Urolithiasis: An Application and Comparison of Six Machine Learning Algorithms
2023 · Clemens Huettenbrink, Wolfgang Hitzl, et al. · Journal of Personalized Medicine · 3
PDF
Impact of Stone Localization before Emergency Ureteral Stenting on Further Stone Treatment
2022 · Clemens Huettenbrink, Valentin Popeneciu, et al. · Urologia Internationalis · 2
Real-World-Daten aus 7 Jahren und 49 Fällen in einem Krankenhaus der Maximalversorgung
2026 · Balz, Philipp, Ell, Jascha · German Medical Science (German Research Foundation)
Supplementary Material for: Downstaging and Pathological Complete Response of Locally Recurrent Sarcomatoid Renal Cell Carcinoma under Pembrolizumab and Lenvatinib: A Case Report and Review of Literature
2023 · J., Ell, P., Balz, et al. · Figshare
Works count: 10
Citation count: 20
H-index: 3
I10-index:
Year
Topic
Type